Literature DB >> 5676805

Therapy of advanced gastrointestinal cancer with 1-3-bis-(2-chlorethyl)-1-nitrosourea (BCNU).

C G Moertel, R J Reitemeier, R G Hahn.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 5676805     DOI： 10.1002/cpt196895652

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  4 in total

Review 1.  Chemotherapy in colorectal cancer.

Authors:  T J McElwain
Journal:  Proc R Soc Med       Date:  1973-12

2.  The chemotherapy of large-bowel cancer. Present status and future prospects.

Authors:  J Horton; C B Hacker; T J Cunningham; R W Sponzo
Journal:  Am J Dig Dis       Date:  1974-11

3.  A phase II trial of 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea (PCNU, NSC 95466) in recurrent malignant brain tumors.

Authors:  L G Feun; D J Stewart; M E Leavens; M A Burgess; N Savaraj; R S Benjamin; G P Bodey
Journal:  J Neurooncol       Date:  1983       Impact factor: 4.130

4.  The hepatotoxicity of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) in rats. Ultrastructural evidence of a delayed microtubular toxicity.

Authors:  T Ducastelle; G Raguenez-Viotte; H Fouin-Fortunet; M Matysiak; J Hemet; J P Fillastre
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.